Pneumococcal Vaccine Urged for Elderly -- Especially With Flu Shot Shortage
Posted on: Wednesday, 20 October 2004, 14:00 CDT
WASHINGTON - The flu-shot shortage makes it more imperative for elderly Americans to get a second, often overlooked vaccine that protects against a type of pneumonia germ that's a common complication of influenza.
Called pneumococcal vaccine, it's a one-time shot for anyone 65 or older. Younger people with heart and lung diseases, diabetes or weak immune systems need it, too.
It's not a replacement for a flu shot; high-risk patients should continue trying to find that.
But many of the same people most vulnerable to flu also are at high risk from this dangerous bacterial infection. They need the pneumococcal vaccine anyway - and this fall marks a good time to go ahead and get it, especially if they can't find a flu shot.
"Absolutely," says Dr. Gregory Poland of the Mayo Clinic, who advises the government on pneumococcal vaccine. "It's a good backup to prevent the complications of influenza."
Despite its name, the pneumococcal vaccine protects against more than pneumonia. It prevents deadly blood infections and meningitis, too, caused by a bacterium called pneumococcus.
Federal data show that each year, 175,000 Americans are hospitalized with pneumococcal-caused pneumonia. In addition, the germ causes more than 50,000 blood infections and up to 6,000 cases of meningitis. Almost 6,000 die.
A childhood vaccine, called Prevnar, has proved very effective at battling seven pneumococcal strains common in babies and toddlers.
But millions of adults are at high risk from additional strains of the germ and thus need the adult version of the vaccine, according to the Centers for Disease Control and Prevention:
Everyone 65 and older.
Anyone with diabetes, heart disease, chronic lung disease except asthma, chronic liver disease or kidney failure.
Anyone with weakened immune systems from cancer, HIV or organ transplants.
People without a functioning spleen or who have sickle cell disease.
Residents of long-term care facilities.
Source: Commercial Appeal, The
Related Articles
- New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
- U.S. Adults 'Needlessly Vulnerable' to Vaccine-Preventable Diseases, According to New Report
- Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers
- Asthmatic Adults At Risk Of Pneumococcal Disease
- 1M Die of Pneumococcal Disease Needlessly
- Adults Need Protection Against Vaccine-Preventable Diseases, Too
- CVS/Pharmacy Offers Flu Vaccinations in Over 4,000 Stores
- New Vaccines Necessary for New Bird Flu Strain: U.S. Official
- HK to Give Free Influenza Vaccination to 250,000 People
- Asthma Doubles Risk Of Pneumococcal Disease
 |
 |
User Comments (0)
RSS Feeds